Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of DCS-T in HER2-positive unresectable metastatic gastric cancer
jRCTs061180096Phase 2Completed
- Start
- Feb 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trastuzumab, docetaxel, cisplatin and tegafur in gastric cancer (GC). Primary endpoint: Objective response rate. Started Feb 2020; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCTs061180096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180096.